why choose us

Clinical Trials Search

Showing 15,430 of 132,963 result(s)
Advanced Platelet-rich Fibrin Combined With Open Debridement in Management of Suprabony Periodontal Defects

Status: Completed

Condition: Periodontitis, Adult

Interventions: Interventional

Date: 2023-02-07

Short-term Evaluation of Motor and Sensory Function in Post-COVID-19 Patients

Status: Completed

Condition: Motor Neuropathy
Sensory Neuropathy

Interventions: Not Provided

Date: 2023-02-07

Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study

Status: COMPLETED

Condition: Hemodynamic Instability

Interventions: Normal saline 20mL will be given intravenously through a syringe pump over 10 minutes

Date: 2023-02-07

Istradefylline Effect Protocol on Parkinson's Disease Tremor

Status: ACTIVE_NOT_RECRUITING

Condition: Parkinson Disease

Interventions: Istradefylline targets adenosine A2A receptors in the basal ganglia, by inhibiting the indirect pathway It is an adjunctive treatment to carbidopa-lev

Date: 2023-02-07

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

Status: Completed

Condition: Healthy Volunteers

Interventions: ITI-333 oral solution

Date: 2023-02-07

A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment

Status: ACTIVE_NOT_RECRUITING

Condition: Rhegmatogenous Retinal Detachment - Macula Off

Interventions: ONL1204 Ophthalmic Solution at one of two doses delivered via intravitreal injection

Date: 2023-02-07

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Status: Completed

Condition: Breast Cancer

Interventions: Participants will receive tucatinib 300mg by mouth twice daily continuously (days 1-28) of each 28 day cycle.

Date: 2023-02-07

Steroids in Occipital Nerve Block for Treatment of Headache

Status: Completed

Condition: Headache

Interventions: 2 mL of bupivacaine 0.5% (5 mg;mL) injected at the origin of each bilateral greater and lesser occipital nerves

Date: 2023-02-07

WayToServePlus: Improving Responsible Alcohol Service Ph II

Status: Completed

Condition: Alcohol Drinking

Interventions: Investigators will test WayToServe Plus in-service component's ability to increase refusal of service to intoxicated patrons in a randomized tria

Date: 2023-02-07

Treatment of Stress and Anxiety in MCI;Mild ADRD

Status: Completed

Condition: Anxiety

Interventions: Brief computerized treatment for anxiety sensitivity

Date: 2023-02-07